SPOBAG AG (SBE) - Total Liabilities
Based on the latest financial reports, SPOBAG AG (SBE) has total liabilities worth €339.85K EUR (≈ $397.32K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
SPOBAG AG - Total Liabilities Trend (2016–2024)
This chart illustrates how SPOBAG AG's total liabilities have evolved over time, based on quarterly financial data. See SBE working capital ratio to evaluate short-term liquidity relative to the company's equity base.
SPOBAG AG Competitors by Total Liabilities
The table below lists competitors of SPOBAG AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Emergent Metals Corp
V:EMR
|
Canada | CA$1.51 Million |
|
Halo Technologies Holdings Ltd
AU:HAL
|
Australia | AU$408.41 Million |
|
Izolacja Jarocin SA
WAR:IZO
|
Poland | zł-18.39 Million |
|
AGS Transact Technologies Limited
NSE:AGSTRA
|
India | Rs-5.35 Billion |
|
Advance Information Marketing Bhd
KLSE:0122
|
Malaysia | RM5.20 Million |
|
GLOW LIFETECH CORP.
F:9DO
|
Germany | €1.48 Million |
|
Avacta Group PLC
LSE:AVCT
|
UK | GBX29.09 Million |
|
ARC Funds Ltd
AU:ARC
|
Australia | AU$1.26 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down SPOBAG AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SBE market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | N/A | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.00 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SPOBAG AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SPOBAG AG (2016–2024)
The table below shows the annual total liabilities of SPOBAG AG from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €137.67K ≈ $160.96K |
+46.52% |
| 2023-12-31 | €93.97K ≈ $109.86K |
-69.03% |
| 2022-12-31 | €303.38K ≈ $354.68K |
+30.51% |
| 2021-12-31 | €232.46K ≈ $271.77K |
+27.48% |
| 2020-12-31 | €182.35K ≈ $213.18K |
-24.00% |
| 2019-12-31 | €239.94K ≈ $280.51K |
+55.23% |
| 2018-12-31 | €154.57K ≈ $180.71K |
+106.68% |
| 2017-12-31 | €74.79K ≈ $87.43K |
+45.15% |
| 2016-12-31 | €51.52K ≈ $60.23K |
-- |
About SPOBAG AG
Leo International Precision Health AG engages in the healthcare technology business in Germany. The company is based in Garching bei München, Germany.